SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bong who wrote (374)8/12/2000 9:33:13 PM
From: aurileano  Respond to of 496
 
Univec actually had quite a good time last week (UNVC up 15%, UNVCW up 50%). I also noticed the Fidelity select Biotech fund had one of the smallest declines of all the sector groups.

The caveat obviously, of course, for both of these is that they are coming off a horrible performance last year.

Any Parkinson's news? Seems to me the hoopla about retinoid regulation about the D2 receptor promoter is much ado about zippo (for those who actually read the papers). Any comments?



To: Mark Bong who wrote (374)8/12/2000 11:31:50 PM
From: aurileano  Respond to of 496
 
Glossy-eyed and trying to keep to many balls in the air at once. Please ignore that last, distracting post.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News